Opportunities for Pan-Spectrum Drugs against Herpes
Breathing Space: Biomarkers in Pulmonary Hypertension
GPCR FlAsH-Walk Mapping: A Leap into the Future
Predicting the Unpredictable
A promising projects portfolio
As of today, CQDM has 35 outstanding research projects for a total of $ 33.3 M invested. These projects are carried out by a network of more than 460 researchers, including 85 graduate students, from 51 research institutions (28 public and 23 private) in Quebec, Canada and internationally. These projects cut across 100 mentors from CQDM’s pharmaceutical companies members.